DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Transfection Reagents and Equipment Market - Global Forecast to 2021" report to their offering.
The global transfection reagents market is expected to reach USD 1.02 Billion by 2021 from USD 715.4 Million in 2016, at a CAGR of 7.5% during the forecast period.
Over the years, the transfection reagents and equipment market has witnessed various technological advancements in equipment as well as reagents to address the requirements of researchers and biotechnology & biopharmaceutical companies. These advancements have led to the development of transfection instruments that are of higher efficiency. It has also resulted in efficient quantitative and qualitative transfection in a wide range of cells, including the hard-to-transfect cells.
In 2016, the reagents segment is expected to account for the largest share of the market, by product. The biochemical method segment is expected to account for the largest share of the market, by method. The academic & research institutes segment is expected to account for the largest share of the market, by end user. The biomedical research segment is expected to account for the largest share of the market, by application.
In 2016, North America is expected to account for the largest share of the global transfection reagents and equipment market, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period, with emphasis on India, China, and Japan. Growth in these countries can be attributed to the increase in research activities conducted in these regions, rapid expansion of the biotechnology and pharmaceutical industry, government as well as private sector support, increase in cancer incidence, and favorable regulatory framework.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopted various strategies such as agreements, collaborations and partnerships, new product launches, expansions, and acquisitions to increase their presence and establish a strong foothold in the global market.
Companies Mentioned:
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- Lonza Group Ltd.
- Maxcyte, Inc.
- Merck KGaA
- Mirus Bio LLC.
- Polyplus-Transfection Sa (Subsidiary of Archimed)
- Promega Corporation
- Qiagen N.V.
-
Thermo Fisher Scientific Inc. (Life Technologies)
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Transfection Technologies Market, By Product
7 Transfection Technologies Market, By Method
8 Transfection Technologies Market, By Application
9 Transfection Technologies Market, By End User
10 Transfection Technologies Market, By Region
11 Competitive Landscape
12 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/bxxpc9/transfection
